A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The intent of this protocol is to screen a new agent for activity in patients with advanced
or recurrent endometrial carcinoma. This phase II trial is studying how well pemetrexed
disodium works in treating patients with advanced or recurrent endometrial carcinoma.